Navigation Links
ACS Announces $57 Million Contract With Missouri HealthNet
Date:3/7/2008

DALLAS, March 7 /PRNewswire-FirstCall/ -- Affiliated Computer Services, Inc. (NYSE: ACS) today announced a contract renewal with the Missouri (MO) HealthNet Division to provide electronic health records and pharmacy benefits management solutions. The contract has a length of up to 10 years and a total value of $57 million if all option years are exercised.

Under this contract, ACS will provide the state with several components of ACS' electronic health records (EHR) solution, including SmartPA(SM) for conducting automated prior authorizations and Prospective Drug Utilization Review. Since 2002, SmartPA has helped contribute more than $85 million in program savings annually in Missouri.

ACS has also provided MO HealthNet with Retrospective Drug Utilization review and academic detailing programs that have enabled the state to save more than $10 million. In 2002, ACS introduced the Get Well program, a disease management program, which helped the state save more than $7 million.

"We have worked closely with the State of Missouri to help them achieve their vision of providing MO HealthNet participants with the best care possible through innovative clinical and technology solutions," said Christopher T. Deelsnyder, ACS senior vice president and managing director, Government Healthcare Solutions. "ACS is noted for listening to our customers, learning about their business requirements, and implementing solutions for participants, providers, and taxpayers in each of the states we serve."

This contract renewal was reflected in the second quarter fiscal year 2008 results and extends a relationship that began in 2001.

ACS will also deploy EHR web tools -- DirectInform(SM), CyberAccess(SM) and DirectCarePro(SM) -- that enable patients, physicians, and pharmacists to access information that will help MO HealthNet Division improve health outcomes, facilitate coordination of care between providers, reduce dangerous drug interactions, minimize duplicate therapies, and reduce unnecessary costs. ACS will also provide Retrospective Drug Utilization Review and federal reporting services using CyberFormance(SM), a fourth component of ACS' EHR suite of web tools.

ACS is a national leader in state healthcare program administration, offering a full spectrum of systems and complementary services through an integrated solution. From care management solutions and child health programs to pharmacy benefits management and traditional Medicaid fiscal agent services, ACS has a proven track record and extensive program management expertise. ACS is also a pioneer in fraud and abuse protection and other cost containment methodologies, and is known for its collaborative approach to client relationships that produce results over the long term. ACS supports more than 23 million program recipients and processes nearly 550 million Medicaid healthcare claims annually, representing close to $50 billion in provider payments. As the nation's largest government program pharmacy benefits administrator, ACS serves 28 states, the District of Columbia and the Department of Labor with drug expenditures totaling more than $13 billion.

For more information about ACS' EHR solutions and ACS' experience in Missouri, please visit http://www.acs-inc.com/informedhealth.

ACS, a global FORTUNE 500 company with 62,000 people supporting client operations reaching more than 100 countries, provides business process outsourcing and information technology solutions to world-class commercial and government clients. The company's Class A common stock trades on the New York Stock Exchange under the symbol "ACS." Learn more about ACS at http://www.acs-inc.com.

The statements in this news release that do not directly relate to historical facts constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to numerous risks and uncertainties, many of which are outside the Company's control. As such, no assurance can be given that the actual events and results will not be materially different than the anticipated results described in the forward-looking statements. Factors could cause actual results to differ materially from such forward-looking statements. For a description of these factors, see the Company's prior filings with the Securities and Exchange Commission, including our most recent filing. ACS disclaims any intention or obligation to revise any forward-looking statements, whether as a result of new information, future event, or otherwise.


'/>"/>
SOURCE Affiliated Computer Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Nfocus Neuromedical Announces Acquisition of StarFire Medical
2. QED International Associates Announces Changes to the HealthShares(TM) Composite and HealthShares(TM) Cancer Indexes
3. Pharos Innovations Announces First Recipient of National Award for Achievements in Chronic Care Programs and Research
4. Trubion Pharmaceuticals Announces Dates for Fourth-Quarter and Year-End 2007 Earnings Conference Call
5. The Hain Celestial Group Announces the Acquisition of MaraNatha(R) and SunSpire(R) Brands
6. Cardiogenesis Corporation Announces Rescheduled Fourth Quarter and Full Year 2007 Earnings Release
7. Derma Sciences Announces Numerous Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming SAWC Conference
8. Milestone Scientific Announces Chicago Dental Societys 143rd Midwinter Meeting Proved Successful
9. Zounds Hearing Enters Moorestown and Announces $225,000 Hearing Partnership With Twilight Wish Foundation
10. Pregis Announces Investor Conference Call to Review 2007 Fourth Quarter and Full Year Financial Results
11. Genoptix Announces Participation at Cowen and Company 28th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... International Protein, ... nutritional and bodybuilding supplements, announced it attended the January ECRM trade show in Hilton ... and nutritional scientist who was determined to create a line of products that would ...
(Date:1/20/2017)... ... , ... “Mary Magdalene: Grace is Greater than Sin”: a unique and ... Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” is the creation of published ... with countless women who had little knowledge of the female characters portrayed in the ...
(Date:1/20/2017)... Farmville, NC (PRWEB) , ... January 20, 2017 ... ... the vPEP ® Oscillating Positive Expiratory Pressure (OPEP) device, was featured in ... article by Doug Pursley, MEd, RRT-ACCS, FAARC, “Analysis of Three Oscillating Positive ...
(Date:1/20/2017)... ... 20, 2017 , ... “The Land of More and More”: a brilliant ... hunger, and shares the simple and achievable answer. “The Land of More and More” ... Fairview Missionary Church in Angola, Indiana where he works with the children’s ministry department. ...
(Date:1/19/2017)... ... 19, 2017 , ... Next week after January 20th, the fear for many ... that circumvent health needs of over 30 million. Many interviews with Dr. Carol Francis ... government public servants were suppose to prioritize. Interviews provided below. , Among ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... YORK , Jan. 19, 2017 This ... the current and future scenario of the global market. ... rising opioid consumption. Severe chronic constipation is a major ... to traditional laxatives. Hence, novel targeted therapy has been ... OIC sufferers, launch of targeted medicines, and growing awareness ...
(Date:1/19/2017)... 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ), ... dysfunction, today announced new additions to its senior leadership ... Medical Officer, and Daniel Geffken as interim ... Jim Carr , Pharm.D. has been promoted to Chief ... to welcome Doug and Daniel to our management team, ...
(Date:1/19/2017)... January 19, 2017 According to a study ... is set to witness a CAGR of 6.5% during the forecast ... will continue to be the leading market for cryotherapy globally ... ... emphasizing on ensuring affordable and adequate supply of gas in order ...
Breaking Medicine Technology: